Truist Financial Forecasts Strong Price Appreciation for Integer (NYSE:ITGR) Stock

Integer (NYSE:ITGR) had its target price boosted by equities research analysts at Truist Financial from $95.00 to $97.00 in a research note issued to investors on Friday,Benzinga reports. The firm currently has a “buy” rating on the medical equipment provider’s stock. Truist Financial’s price objective indicates a potential upside of 14.39% from the stock’s previous close.

ITGR has been the topic of a number of other reports. Wells Fargo & Company restated an “equal weight” rating and issued a $80.00 price objective (down from $132.00) on shares of Integer in a report on Friday, October 24th. Wall Street Zen cut Integer from a “buy” rating to a “hold” rating in a research note on Sunday, January 25th. Argus downgraded Integer from a “buy” rating to a “hold” rating in a report on Friday, October 24th. Citigroup increased their price objective on Integer from $75.00 to $92.00 and gave the company a “neutral” rating in a report on Friday. Finally, Piper Sandler cut their target price on Integer from $155.00 to $82.00 and set an “overweight” rating on the stock in a research report on Friday, October 24th. Four equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $101.25.

Integer Price Performance

ITGR stock opened at $84.80 on Friday. The business’s 50-day moving average is $82.83 and its two-hundred day moving average is $88.12. The company has a debt-to-equity ratio of 0.69, a current ratio of 3.32 and a quick ratio of 2.45. The firm has a market capitalization of $2.97 billion, a P/E ratio of 29.55, a P/E/G ratio of 0.77 and a beta of 0.77. Integer has a 1 year low of $62.00 and a 1 year high of $136.06.

Integer (NYSE:ITGR) last released its earnings results on Thursday, February 19th. The medical equipment provider reported $1.76 earnings per share for the quarter, topping analysts’ consensus estimates of $1.70 by $0.06. The firm had revenue of $472.06 million for the quarter, compared to analyst estimates of $462.73 million. Integer had a net margin of 5.55% and a return on equity of 13.26%. The business’s quarterly revenue was up 5.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.43 earnings per share. Integer has set its FY 2026 guidance at 6.290-6.780 EPS. Analysts anticipate that Integer will post 6.01 earnings per share for the current fiscal year.

Integer announced that its Board of Directors has initiated a share repurchase plan on Tuesday, November 4th that permits the company to repurchase $200.00 million in shares. This repurchase authorization permits the medical equipment provider to repurchase up to 8.3% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s leadership believes its shares are undervalued.

Institutional Investors Weigh In On Integer

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Emerald Advisers LLC boosted its stake in Integer by 1,542.0% during the 2nd quarter. Emerald Advisers LLC now owns 103,824 shares of the medical equipment provider’s stock worth $12,767,000 after purchasing an additional 97,501 shares during the period. New York State Common Retirement Fund raised its holdings in shares of Integer by 12.0% in the third quarter. New York State Common Retirement Fund now owns 267,613 shares of the medical equipment provider’s stock valued at $27,652,000 after buying an additional 28,650 shares during the last quarter. Massachusetts Financial Services Co. MA purchased a new stake in shares of Integer in the third quarter valued at about $41,938,000. Public Sector Pension Investment Board boosted its stake in shares of Integer by 14.9% during the third quarter. Public Sector Pension Investment Board now owns 136,632 shares of the medical equipment provider’s stock worth $14,118,000 after buying an additional 17,699 shares during the period. Finally, Wakefield Asset Management LLLP purchased a new position in shares of Integer during the second quarter worth about $1,118,000. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Key Headlines Impacting Integer

Here are the key news stories impacting Integer this week:

• Positive Sentiment: Q4 results beat expectations — EPS $1.76 vs. $1.70 est and revenue $472.1M vs. $462.7M; full-year results showed 8% sales growth and strong adjusted EPS growth, supporting the company narrative of improving margins and growth execution. Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2025
• Positive Sentiment: Truist raised its price target to $97 and kept a “buy” rating, signaling an analyst view of meaningful upside versus the current level. Benzinga — Truist raises target
• Neutral Sentiment: Wells Fargo also raised its target (to $84) but kept an “equal weight” rating — a modest signal that the stock is fairly valued near current levels rather than a clear endorsement. Benzinga — Wells Fargo raises target
• Neutral Sentiment: Full earnings materials (slide deck and call transcript) are available for deeper review of segment trends, backlog and margin drivers — useful for investors deciding if the beat is sustainable. Q4 Results – Earnings Call Presentation Q4 Earnings Call Transcript
• Negative Sentiment: Market reaction was mixed: some investors sold after management’s FY2026 guidance was viewed as softer than hoped, leading to an earlier pullback. Zacks notes shares fell despite the beat because guidance tempered enthusiasm. ITGR Shares Down Despite Q4 Earnings & Revenues Beat Estimates
• Negative Sentiment: Wider context: guidance midpoint and revenue outlook left some analysts noting modest downside risk versus certain targets, which could cap upside until visibility improves. MarketBeat — Earnings & Guidance Details

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.